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Background: The epidermis forms a critical barrier that is maintained by orchestrated programs of proliferation,
differentiation, and cell death. Gene mutations that disturb this turnover process may cause skin diseases. Human
GASDERMIN A (GSDMA) is frequently silenced in gastric cancer cell lines and its overexpression has been reported
to induce apoptosis. GSDMA has also been linked with airway hyperresponsiveness in genetic association studies.
The function of GSDMA in the skin was deduced by dominant mutations in mouse gasdermin A3 (Gsdma3), which
caused skin inflammation and hair loss. However, the mechanism for the autosomal dominance of Gsdma3
mutations and the mode of Gsdma3’s action remain unanswered.
Results: We demonstrated a novel function of Gsdma3 in modulating mitochondrial oxidative stress. We showed
that Gsdma3 is regulated by intramolecular fold-back inhibition, which is disrupted by dominant mutations in the
C-terminal domain. The unmasked N-terminal domain of Gsdma3 associates with Hsp90 and is delivered to
mitochondrial via mitochondrial importer receptor Tom70, where it interacts with the mitochondrial chaperone Trap1
and causes increased production of mitochondrial reactive oxygen species (ROS), dissipation of mitochondrial membrane
potential, and mitochondrial permeability transition (MPT). Overexpression of the C-terminal domain of Gsdma3 as well
as pharmacological interventions of mitochondrial translocation, ROS production, and MPT pore opening alleviate the
cell death induced by Gsdma3 mutants.
Conclusions: Our results indicate that the genetic mutations in the C-terminal domain of Gsdma3 are gain-of-function
mutations which unmask the N-terminal functional domain of Gsdma3. Gsdma3 regulates mitochondrial oxidative stress
through mitochondrial targeting. Since mitochondrial ROS has been shown to promote epidermal differentiation, we
hypothesize that Gsdma3 regulates context-dependent response of keratinocytes to differentiation and cell death signals
by impinging on mitochondria.
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The epidermis forms a physical barrier to prevent water
loss and an immune barrier to defend against environ-
mental insults. This barrier function is maintained by
the epithelial keratinocytes which undergo constant pro-
liferation, differentiation, and cell death. Gene mutations
which disturb this turnover process are considered as
the risking factors for skin diseases [1].* Correspondence: ltyang@nhri.org.tw
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creativecommons.org/publicdomain/zero/1.0/Human GASDERMIN A (GSDMA) is expressed pri-
marily in the epithelial cells of the skin, upper gastro-
intestinal tract, and the lung [2–4]. The function of
GSDMA is in dispute. GSDMA is frequently silenced in
gastric cancer cell lines [5] and has been reported to in-
duce apoptosis when overexpressed in gastric cancer
cells [6]. GSDMA has also been linked with airway
hyperresponsiveness; polymorphisms in GSDMA are as-
sociated with asthma susceptibility, and risk alleles on
asthma-associated locus are linked with increased
GSDMA gene expression [2, 7, 8]. The expression of
GSDMA in the epidermis and gastric epithelium is limited
to the suprabasal layer; however, GSDMA expression wase distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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airway and forestomach epithelium [2, 9]. Interestingly, an
expansion of GSDMA-expressing cells was found in the
epidermis overlying the tumor, suggesting that GSDMA
may mediate certain stress responses [9].
The function of GSDMA in the skin is unclear. Among
three GSDMA orthologs (Gsdma1-3) in mice, Gsdma1
and Gsdma3 are expressed in the differentiating kerati-
nocytes of the epidermis and hair follicles [10]. Only
mice bearing mutations in Gsdma3 were found to
display autosomal dominant phenotypes, including
epidermal hyperplasia, abnormal hair follicle differen-
tiation, and progressive hair loss [11]. The underlying
mechanism of these defects remains unexplained, as
studies using different mutant mouse strains lead to
different conclusions. Roles for Gsdma3 in epidermal
proliferation and differentiation [9, 12–15], apoptosis
and necrosis [16, 17], and inflammation-mediated hair
follicle destruction [18, 19] have been proposed.
The Gsdm/GSDM family proteins are characterized by
the presence of a Gasdermin domain (PFAM identifier
PF04598), which contains nine highly conserved leucine-
rich regions distributed throughout the entire protein
[4]. Three spontaneous mutations and six ENU-induced
mutations have been characterized in Gsdma3 gene
(Fig. 1a). Interestingly, all the dominant mutation sites
were located in the C-terminal portion of Gsdma3, indi-
cating a critical role of this segment. Whether the dom-
inant phenotypes of these Gsdma3 mutants are due to
haploinsufficiency or gain-of-function mutations has not
been examined. The haploinsufficiency theory proposes
that the mutant protein may be rapidly degraded by
missense-mediated instability, whereas the gain-of-
function theory proposes that these dominant muta-
tions may generate a constitutively activated protein.
Mitochondrial membrane permeabilization is a com-
mon step in mitochondria-mediated cell death. One type
is initiated at the mitochondrial outer membrane by
oligomerization of the pore-forming Bak and Bax, which
leads to the release of the cytochrome c and AIF from the
mitochondrial intermembrane space into the cytosol to-
induce caspase-dependent and -independent apoptosis.
The other type is initiated at the mitochondrial inner
membrane by opening of the mitochondrial permeability
transition (MPT) pore, which leads to mitochondrial
swelling and cell death through apoptosis or necrosis
depending on the extent of the MPT. The putative MPT
pore complex contains the voltage-dependent anion chan-
nel (VDAC), the adenine nucleotide translocase (ANT),
and cyclophilin D (CypD) [20]. MTP pore opens in re-
sponse to increased Ca2+ concentrations in the mitochon-
drial matrix. Moreover, oxidative stress, mitochondrial
depolarization, and depletion of adenine nucleotide may
sensitize the MPT pore to Ca2+ concentrations [21].Although dominant mutations of Gsdma3 have been
associated with abnormal skin phenotypes, the mechan-
ism for the autosomal dominance of Gsdma3 mutations
and the mode of Gsdma3’s action remain unanswered.
Here, we demonstrated that the mutations of Gsdma3
disrupted the interactions between the N- and C-
terminal domains. The unmasked N-terminal functional
domain was then delivered to mitochondria, where it in-
duces mitochondrial oxidative stress and cell death. Our
data suggest a novel function of Gsdma3 in regulating
mitochondrial homeostasis, which potentially involves in
cellular differentiation and cell death.
Methods
Cells and reagents
HaCaT (human epidermal keratinocytes) and HEK293T
(human kidney epithelial cells) were grown in DMEM
(Biowest, Kansas City, MO, USA) plus 10 % FBS (Bio-
west) and 1X penicillin/streptomycin (Biowest). DNA
transfection of HEK293T and HaCaT cells was carried
out using the PolyJet and GenJet transfection reagents
(SignaGen laboratories), respectively. Radicicol (Rad),
N-acetyl-L-cysteine (NAC), bongkrekic acid (BkA),
cyclosporin A (CsA), NecroX-5 (Nex-5), ABT-888, and E-
64D were purchased from Enzo life Sciences; Necrostatin-
1 (Nec1) and desipramine (Dpa) were from Santa Cruz
Biotechnology.; z-VAD-fmk was from InvivoGen.
Plasmid construction
An illustration of the Gsdma3 mutations and the
constructs used in this study is provided in Fig. 1b. For
the V5-tagged constructs, the corresponding cDNAs in
pENTR2B were recombined with pCDNA3.2/V5/DEST
(Invitrogen) using LR clonase (Invitrogen). The Gsdma3/
V5 construct was constructed through PCR amplification
with primers bearing restriction sites for insertion of
Gsdma3 cDNA (Genecopeia ID#Mm1921) without a stop
codon and subsequent cloning into the SalI/EcoRI sites of
pENTR2B (Invitrogen). The Rim3-type (Gsdma3 A384T)
and I359N-type constructs were generated via site-
directed mutagenesis (1124 G to A for Rim3-type and
1158 T to A for I359N-type) of Gsdma3 cDNA in
pENTR2B, following the instructions for the QuikChange
Site-Directed Mutagenesis kit (Agilent Technologies). The
M1Btlr-type (Gsdma3 K366 stop) construct was con-
structed via PCR amplification of a.a. 1-365 of the Gsdma3
cDNA and cloned in pENTR2B. For Gsdma3/mh and
Rim3/mh constructs, the corresponding SalI-NotI cDNA
fragments from the pENTR2B constructs were cloned
into XhoI/NotI sites of pCDNA3.1-myc-His(-)B (Invitro-
gen). For the rest of myc-tagged constructs, the corre-
sponding cDNA sequences were PCR amplified and
cloned into pCDNA3.1-myc-His(-)A to generate a myc/



















Fig. 1 Illustration of the Gsdma3 mutants and constructs used in this study. (a) Multiple amino acid sequence alignment of human GSDMA and
mouse Gsdma1-3 using Vector NTI software. The yellow residues are identical; the blue residues are conserved; and the green residues are similar.
The rectangular boxes indicate putative leucine zipper motifs. Nine conserved leucine-rich regions across the family members are indicated with horizontal
bars with Roman numerals (based on [4]). The asterisk indicates the end of the N-Gsdma3 construct, which contains the leucine-rich region I-IV; the
arrowhead marks the beginning of the C-Gsdma3 construct, which contains the leucine-rich region V-XI. The mutation sites in Gsdma3 are indicated
with arrows with amino acid substitutions, and the type of mutation is shown in parentheses. The dotted underlining indicates the peptide sequence
used to generate the rabbit polyclonal antibody against Gsdma3. (b) A schematic representation of the Gsdma3 and mutant Gsdma3 constructs. The
N-terminal (A.A.1-227, hereafter referred to as N-Gsdma3) and C-terminal (A.A. 229-464, hereafter referred to as C-Gsdma3) portions are indicated. The
gray box highlights the linker region between the putative N- and C-terminal domains. The different types of C-terminal tags are labeled
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cloned into pIRES-hrGFP-1a (Agilent Technologies) to
obtain a 3xflag tag and achieve IRES-mediated GFP
expression. Untagged C-Gsdma3 and C-Rim3 were con-
structed through PCR amplification (with the stop codon
sequence) and cloned into pCDNA3.1-myc-His(-)A. All
constructs were verified through DNA sequencing and
western blot analysis. The primer sequences for PCR clon-
ing and mutagenesis are listed in Table 1.
Flow cytometry analysis
HEK293T cells were seeded at a density of 2x105 cells/
well in 6-well plates and were transfected with pIRES-
GFP-1a vector-based constructs as indicated in the
figures. The transfection efficiency was usually 50-60 %
based on the GFP signal from pIRES-hrGFP-1a-trans-
fected cells. Sixteen to twenty hours after transfection,























C-Gsdma3 (no tag) PCR cloning
-pCDNA3.1-myc-His(-)A
C-Gsdma3Rim3 (notag) PCR cloning
-pCDNA3.1-myc-His(-)Amitochondrial ROS detection, the cells were loaded with
2.5 μM MitoSox Red (Molecular Probe) in HBSS, incu-
bated in a 5 % CO2 incubator at 37 °C for 15 min,
washed with PBS and then analyzed on a FACSCalibur
(BD Biosciences) using CellQuest Pro software. To
assess the mitochondrial membrane potential and
plasma membrane integrity, cells were washed with
HBSS, loaded with 1 nM DiIC1(5) (Molecular Probe)
in HBSS, and incubated in a 5 % CO2 incubator at
37 °C for 15 min. The cells were then washed with
PBS, and 7-aminoactinomycin D (7-AAD, 200 ng/ml,
Molecular Probe) was added 10 min before flow
cytometry analysis. For quantitative analysis, an equal
number (approximately 20,000 cells) of GFP+ cells
was collected for data analysis using FlowJo software
(Tree Star, Inc.). Transfected cells were treated with
pharmacological inhibitors 16 hours before flow
cytometry.tructs
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fractionation, and proteinase K treatment
HEK293T cells in 6 cm dish were transfected with differ-
ent combinations of plasmid constructs, as indicated in
the figures; the total amount of plasmid in each transfec-
tion was kept constant across the samples through co-
transfection with the pCDNA3 vector plasmid. Western
blotting and immunoprecipitation were carried out as
previously described [22]. The mitochondria/cytosol
fractionation of transfected cells was carried out using a
Mitochondria Isolation Kit for cultured cells (Pierce) ac-
cording to the manufacturer’s protocol. The measure-
ment of cytochrome c released from the mitochondria
was performed according to the protocol described pre-
viously [23]. Proteinase K treatment of fractionated
mitochondria was performed in SHE buffer (0.25 M
sucrose, 1 mM EDTA, 20 mM HEPES-NaOH, pH 7.4)
in the presence or absence of 5 μg/ml proteinase k (PK)
for 30 min on ice. The sources and dilutions of the
primary antibodies used in these assays are listed in
Table 2. An anti-Gsdma3 antibody was raised in rabbits
using the peptide sequence QMISEEPEEEKLI (Yao-Hong
Biotechnology, New Taipei City, Taiwan).
Immunostaining, apoptosis/necrosis detection, and
TUNEL assays
Immunostaining was performed following the standard
procedures as described elsewhere [24]. The sources and
dilutions of the primary antibodies used in these assays
are listed in Table 2. The fluorescence signals were im-
aged using an Olympus DP71 CCD device attached toTable 2 List of the primary antibodies and dilutions used for western
Antigen Antibody Species
V5 monoclonal mouse sv5-pk
V5 polyclonal rabbit
myc monoclonal mouse 9E10













Tom70 monoclonal mousean Olympus BX51 microscope with a DP controller and
DP manager software or with a Leica TCS SP5 II con-
focal microscope system with Leica LAS AF software. A
GFP-Certified Apoptosis/Necrosis detection kit (Enzo)
was used to analyze apoptosis/necrosis according to the
manufacturer’s instructions. TUNEL assays were con-
ducted using the DeadEnd Fluorometric TUNEL system
(Promega) following the manufacturer’s instructions.
Proteomics analysis
The protein bands detected via SDS-PAGE by silver
staining using the SiverQuest staining kit (Invitrogen)
were manually excised from the gel, reduced, alkylated
and trypsin digested as described previously [25]. A
nanoAcquity UPLC-nano-ESI-MS/MS analysis was ap-
plied to the extracted peptides using a Synapt G2 HDMS
mass spectrometer (Waters Corp.). Peptides were
trapped and desalted in a nanoAcquity UPLC®Trap
Column (180 μm× 20 mm, 5 μm Symmetry® C18) using
99 % solvent A/1 % solvent B at 5 μL/min for 3 min and
were then separated in a nanoACQUITY UPLC BEH
130 C18 reverse-phase column (Waters Corporation)
using a linear-gradient of 3-60 % solvent B at 200–
300 nl/min over 85 min. Data-directed analysis was used
for data acquisition. A 1-second scan was applied to ob-
tain an MS survey at a range of 300-2000 m/z. The 5
most abundant ions with a charge state of 2+, 3+, or 4+
were selected for MS/MS analysis and were dynamically
excluded for 70 seconds. MS/MS spectra (range 50-
2000 m/z, 1.2 sec/scan) were obtained by ramping the
collision cell energy from 15-30 V for low molecularblotting/ immunoprecipitation (WB/IP) and immunostaining (ICC)
Company WB/IP ICC
Santa Cruz 1:500/IP(2 μg) 1:300
Genetex 1:5000 1:200
Santa Cruz 1:1000/IP(2 μg) 1:200
Agilent Tech 1:2000/IP(2 μg)
Genetex 1:1000
Santa Cruz 1:500
Home made 1:500 1:200
Genetex 1:5000
Genetex 1:5000




Genetex IP (2 ug)
Genetex 1:4000
Millipore 1:2500
Santa Cruz 1:2000/IP(2 ug)
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mass accuracy was 20 ppm for the parent ion and
0.25 Da for the fragment ions. The acquired raw data
were submitted to the ProteinLynx Global Server and
exported as PKL files for human protein database
searches at UniProt using a Mascot Daemon 2.4.1 ser-
ver. The data were filtered using a MASCOT P < 0.05.Western blot quantification, confocal microscopy
processing, and statistical analysis
Western blot X-ray films were scanned using an ArtixS-
can 2500f scanner (Microtek), and the digital image files
were analyzed using ImageJ (NIH) according to the Gel
Analysis method documented online. Images acquired in
a confocal microscopy system with a z-step of approxi-
mately 1 μm were processed to determine the degree of
colocalization using the Imaris software (Bitplane).
Briefly, the degree of immunofluorescence overlap be-
tween the target protein and the mitochondrial marker,
represented by % region of interest (ROI) colocalized
with Tom20, was calculated from a minimum of ten
cells. The ROI was determined by masking the images
such that the pixels selected in each channel closely out-
lined the area of immunofluorescence staining; the
threshold was then calculated by the program using the
default settings. A colocalization channel was created,
and the fraction of the ROI that colocalized with the
mitochondrial marker was determined for each image.
Statistical analysis was carried out in Excel 2003 (Micro-
soft), and statistical significance was determined with
two-tailed Student’s t tests for comparing two independ-
ent groups, or with one-way ANOVA using α = 0.05 for
comparing more than two groups. In all experiments P
< 0.05 is considered statistically significant; *, P < 0.05; **,
P < 0.01; ***, P < 0.001.Results
The N-terminal domain of Gsdma3 harbors the cell
death-inducing ability
Sequence alignment of human and mouse GSDMA/
Gsdma family members suggests that Gsdma3 consists
of highly conserved N-terminal and C-terminal domains
that are connected by a variable linker region. Notably,
known autosomal dominant mutations, including Bsk,
Dfl, Re-den, Fgn, Rco2, Rim3, AE, M1Btlr, and I359N, are
located in the C-terminal domain (Fig. 1a). To investi-
gate the structure-function relationship of Gsdma3, we
generated various expression constructs to express wild-
type, truncated-type, and mutant-type variants with
different tagging sequences (Fig. 1b). Since Rim3-type
(A348T) mutation changes the highly conserved residue
in the seventh leucine-rich region (LRR) of Gsdma3
protein and six out of nine dominant mutations arelocated in this LRR, we used mainly this mutant protein
(Gsdma3Rim3) as a paradigm for functional study of the
missense mutation.
Previous overexpression study of GSDMA and
Gsdma3 implicated a role in apoptosis [6, 16]; we there-
fore expressed wild-type and mutant Gsdma3 in epithe-
lial cells and examined the cell death phenotypes.
HaCaT cells transfected with expression vectors for
wild-type and mutant Gsdma3 were first live-cell stained
with Annexin V-Cy3 plus 7-AAD, and then immuno-
stained for the tagged protein (Fig. 2a). We found that
the cells expressing wild-type Gsdma3 (Gsdma3wt), N-
terminal portion of Gsdma3 (N-Gsdma3) or Gsdma3Rim3
displayed slightly higher levels of early apoptosis staining
(Annexin V+) than that of the cells expressing the C-
terminal portion of Gsdma3 (C-Gsdma3) and C-
terminal portion of Gsdma3Rim3 (C-Gsdma3Rim3), but it
is not statistically significant (P = 0.47). The expression
of C-Gsdma3 and C-Gsdma3Rim3 induced very little late
apoptosis (Annexin V+ 7AAD+), and Gsdma3-expressing
cells (16.4 ± 6.1 %), N-Gsdma3-expressing cells (29.6 ±
7.2 %), and Gsdma3Rim3-expressing cells (60.5 ± 9.9 %)
displayed higher level of late apoptosis staining than C-
Gsdma3-expressing cells (P < 0.005) (Fig. 2b). The
TUNEL assays were also performed in transfected
HaCaT cells to detect the late apoptosis (Fig. 2c). Quan-
tification of the TUNEL staining results revealed that
Gsdma3-, N-Gsdma3- and Gsdma3Rim3-expressing cells
displayed a higher level of TUNEL+ staining than that of
C-Gsdma3-expressing (P < 0.5) (Fig. 2d). Interestingly,
we found that Gsdma3Rim3-expressing cells had a higher
late apoptosis staining than Gsdma3-expressing cells
(Fig. 2b, d).
To quantify the cell death status in a more objective
manner, we used flow cytometry to analyze the plasma
membrane integrity (7AAD permeability) and mitochon-
drial membrane potential (△ΨM) in HEK293T cells ex-
pressing Gsdma3 and its variants (Fig. 2e, f). The pIRES-
hrGFP-1a vector was used to express flag-tagged Gsdma3
and variants together with internal ribosome entry site-
driven GFP. Twenty thousand GFP+ cells for each trans-
fection were collected for flow cytometry analysis, and we
found that N-Gsdma3-expressing cells displayed a signifi-
cant increase in the fractions of cell death (7AAD+ stain-
ing) and △ΨM depolarization than Gsdma3-expressing
cells or vector-transfected cells. In contrast, the fractions
of cell death and cells with △ΨM depolarization in C-
Gsdma3-expressing cells were comparable to vector-
transfected cells. As the GFP signal in cells transfected
with flag tagged-Gsdma3Rim3 was below the detection
limit of flow cytometry, we transfected HEK293T cells
with mixtures of the flag tagged-Gsdma3Rim3 and the V5
tagged-Gsdma3wt plasmids (1:2 ratio). Interestingly, coex-


































































































































































Fig. 2 (See legend on next page.)
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Fig. 2 The N-terminal domain of Gsdma3 harbors the cell death-inducing ability of Gsdma3. (a) Immunostaining of HaCaT cells transfected with
the indicated plasmid constructs. Cells were live-cell stained with Annexin V-Cy3 and 7-AAD and immunostained for the tagged constructs.
Arrows, Annexin V-Cy3 cell surface staining (red); arrowheads, 7-AAD nuclear staining (red); Tag-specific staining (green). (b) Quantification of the
apoptosis/necrosis staining. The percentage of Annexin V+ (early apoptosis) cells and the percentage of Annexin V+7AAD+ (late apoptosis) cells
among the tag+ cells (mean + s.d., n > 5 microscopy fields from three independent experiments) are shown for each transfected construct.
Vector-transfected cells exhibited 0.1 ± 0.2 % early apoptosis and 1.4 ± 0.9 % late apoptosis. (c) TUNEL staining in HaCaT cells transfected with the
indicated plasmid constructs, followed by immunostaining for the tagged constructs. TUNEL (green) and tag-specific (red) staining results are
shown. DAPI counterstains the nuclei in blue. Scale bar, 50 μM. (d) Quantification of the TUNEL stainings by the percentage of TUNEL+ cells
among tag+ cells (mean + s.d., n > 6 microscopy fields from two independent experiments). Vector-transfected cells displayed a 1.32 ± 0.57 %
TUNEL+ signal. (e, f) Flow cytometry analysis of cell death and mitochondrial membrane potential (MMP) depolarization. HEK293T cells were
transfected with flag tagged-constructs and the vector pIRES-hrGFP-1a, stained with 7-AAD and DiIC1(5), followed by flow cytometry analysis.
Quantifications results show the fold increase (mean + s.d., n >3) in the fraction of dead (7AAD+) GFP+ cells and mitochondrial membrane
potential depolarization (DiIC1(5)low) GFP
+ cells over that of pIRES-GFP-1a vector-transfected cells (Dead, 1.88 ± 0.7 %, Low MMP, 4.76 ± 2.14 %).
*, P < 0.05; **, P < 0.01; ***, P < 0.001; n.s., not significant
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expression of Gsdma3wt alone. Collectively, these re-
sults indicate that C-Gsdma3 and C-Gsdma3Rim3 do not
cause cell death, and that N-terminal domain of
Gsdma3 harbors the cell death-inducing ability and the
Rim3-type (A348T) mutation in the C-terminal domain
may play a regulatory role.
Coimmunoprecipitation analyses reveal an association
between the N- and C-terminal domains of Gsdma3
HEK293T cells transfected with V5-tagged Gsdma3 plas-
mid displayed an appreciable level of expression, but the
cells transfected with an equal amount of V5-tagged
Gsdma3Rim3 plasmid exhibited reduced levels of expres-
sion, possibly due to its cytotoxicity (Additional file 1:
Figure S1A). Interestingly, the expression level of V5
taggd-Gsdma3 was significantly reduced as the amount
of the co-transfected Rim3/mh or N-Gsdma3/mh plas-
mid construct increased (Fig. 3a, b). These dominant ef-
fects prompted us to investigate the interaction between
Gsdma3 and its variants, which was further demonstrated
by reciprocal co-immunoprecipitation analyses, where
Gsdma3 was found to self-associate and associate with
Gsdma3Rim3, but the level of Gsdma3-Gsdma3Rim3 com-
plex formation was lower than that of Gsdma3wt self-
association (Additional file 1: Figures S1B-S1D).
Moreover, the co-immunoprecipitation results first
demonstrated that the N-Gsdma3, but not C-Gsdma3,
associated with full-length Gsdma3wt (Fig. 3c), and that
N-Gsdma3 interacted with C-Gsdma3 (Fig. 3d) and self-
associated (Fig. 3e). Importantly, the Rim3-type muta-
tion rendered C-Gsdma3 (C-Gsdma3Rim3) unable to as-
sociate with N-Gsdma3 (Fig. 3d). Analysis of HEK293T
cells co-expressing myc-His tagged-N-Gsdma3 with
untagged C-Gsdma3 or C-Gsdma3Rim3 confirmed that
the expression of C-Gsdma3, but not C-Gsdma3Rim3,
increased the N-Gsdma3 protein expression (Additional
file 1: Figure S1E). These results suggest that the
Gsdma3 protein can be stabilized by an associationbetween its N- and C-terminal portions, which also me-
diates self- and intermolecular associations.Mitochondrial targeting of N-Gsdma3 is masked by C-
Gsdma3
To gain further insight into the molecular function of
Gsdma3, we next investigated the subcellular localization
of N-Gsdma3, C-Gsdma3, and full-length Gsdma3wt in
HaCaT cells. Immunostaining results from transfected
HaCaT cells revealed that both Gsdma3 and C-Gsdma3
displayed diffuse cytosolic staining, while N-Gsdma3
mainly displayed a perinuclear punctate staining (Fig. 4a).
Double-immunostaning of HaCaT cells transfected with
Gsdma3, N-Gsdma3, Gsdma3Rim3, and Gsdma3I359N ex-
pression plasmids (Fig. 1b) with tag-specific antibody and
markers of individual organelles (ER, mitochondria, Golgi,
peroxisomes, and lysosomes) showed that N-Gsdma3 as
well as Gsdma3Rim3, and Gsdma3I359N partially colocalized
with the mitochondrial marker Tom20 (Fig. 4b, d). Inter-
estingly, N-Gsdma3, Gsdma3Rim3, and Gsdma3I359N often
colocalized with fragmented mitochondria. Gsdma3Rim3
partially colocalized with Tom20, albeit less than N-
Gsdma3 did. Remarkably, co-expressing C-Gsdma3 relo-
cated N-Gsdma3 to the cytosol (Fig. 4c). Using immuno-
staining, we confirmed that N-Gsdma3 also partially
colocalized with mitochondria in HEK293T and A549
lung epithelial cells (Additional file 2: Figure S2),
suggesting that mitochondrial targeting of N-Gsdma3
is not a cell type-specific mechanism. To confirm
mitochondrial targeting of N-Gsdma3, we performed
mitochondria/cytosol fractionations of transfected
HEK293T cells and immunoblotting analyses (Fig. 4e).
Quantitative analysis showed that N-Gsdma3, but not
C-Gsdma3, was enriched in the mitochondrial fraction
(Fig. 4f ). Collectively, our data suggest that the N-
terminal domain of Gsdma3 targets mitochondria,







































































































































































































































































1 0.89 0.88 0.52 0.36
Fig. 3 Coimmunoprecipitation analyses of the association between the N- and C-terminal domains of Gsdma3. (a, b) Immunoblot analysis of
HEK293T cells transfected with the indicated plasmid constructs. Relative densitometry levels normalized to β-actin expressions are indicated.
(c, d, e) Co-immunoprecipitation and immunoblot analysis of HEK293T cells transfected with the indicated plasmid constructs. Whole cell lysates
(WCL) were split in half, immunoprecipitated and immunoblotted with the indicated antibodies. Asterisks indicate non-specific reactive bands.
The molecular weight of the protein standards in kilodaltons (kDa) is indicated. Non-specific bands corresponding to the IgG heavy chain (IgGh)
and light chain (IgGl) are indicated. Models of the putative domain interaction are listed in each panel
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in mitochondria
The fragmented mitochondria observed in the N-
Gsdma3-expressing cells prompted us to use flow cy-
tometry to examine the levels of mitochondrial reactive
oxygen species (ROS) in transfected cells (Fig. 4g). We
detected an increase of mitochondrial ROS level in N-Gsdma3- and Gsdma3wt-expressing cells compared with
pIRES-hrGFP-1a vector -transfected cells (P < 0.5)
(Fig. 4h). In contrast, levels of mitochondrial ROS in C-
Gsdma3-expressing cells and vector control-transfected
cells were comparable. Furthermore, coexpression of
Gsdma3Rim3 and Gsdma3wt (1:2 ratio) also resulted in an





















































































































































































Fig. 4 (See legend on next page.)
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Fig. 4 N-Gsdma3 partially colocalizes with mitochondria and induces mitochondrial ROS production. (a) Immunostaining of HaCaT cells
transfected with the Gsdma3/V5, C-Gsdma3/mh, or N-Gsdma3/mh plasmid. Scale bar: 30 μM. (b) HaCaT cells transfected with Gsdma3/V5, N-Gsdma3/
mh, Rim3/mh, and I359N/V5 plasmids were double immunostained for the tag and the mitochondrial marker Tom20. The region of interest (ROI) is
determined by masking the images using the Imaris software such that the pixels selected in green and red channels closely outline the area of
immunofluorescence staining. Arrows indicate partial colocalization; arrowheads point to mitochondria; Scale bar: 20 μM. (c) HaCaT cells were
transfected with both the C-Gsdma3 and N-Gsdma3/mh plasmids and double immunostained for the myc tag and Gsdma3. The arrowheads indicate
the cells expressing a low amount of C-Gsdma3; the arrows indicate the cells expressing a high amount of C-Gsdma3. Scale bar, 20 μM. The color
coding indicates the secondary antibody labeling. DAPI counterstains the nuclei in blue. (d) Quantification of the colocalization of N-Gsdma3 and
Gsdma3Rim3 with the mitochondrial marker. The bar graph shows the % ROI colocalized with Tom20 (mean + s.d., n > 10 from 5-7 z-stacked confocal
images). ***, P < 0.01 (e) Immunoblot analysis of mitochondrial and cytosolic fractions prepared from transfected HEK293T cells. Cox4 (a mitochondrial
marker) and GAPDH (a cytosol marker) immunoblots confirmed the purity of the fractionations. (f) Quantification of the mitochondria/cytosol distribution
based on relative densitometry levels from mitochondrial and cytosolic fractions. The bar graph represents mitochondrial/cytoplasmic ratio relative to
Gsd (mean + s.d., n = 3). (g) Flow cytometry analysis of the MitoSox Red staining in HEK293T cells transfected with the Gsdma3/flag (Gsdma3), N-Gsdma3/
flag (N-Gsdma3), C-Gsdma3/flag (C-Gsdma3), Rim3/flag plus Gsdma3/mh in a ratio of 1:2 (Rim3 +Gsd), and control pIRES-hrGFP-1a (pIRES) plasmids.
(h) Quantification of the MitoSox Red staining results by the fold increase of MitoSox Red staining in the fraction of GFP+ cells (mean + s.d., n = 3) over
that of vector-transfected cells (average = 3.79 ± 1.53 %).*, P < 0.05; **, P < 0.01; n.s., not significant
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Gsdma3 increases mitochondrial ROS production.
C-Gsdma3 alleviates the cytotoxicity of Gsdma3 mutants
We reasoned that if the mutations in C-Gsdma3 dis-
rupted the association between N-Gsdma3 and C-
Gsdma3 and exposed N-Gsdma3, then exogenous
expression of the C-Gsdma3 might inhibit the cytotox-
icity of Gsdma3 mutants. 293 T cells were transfected
with N-Gsdma3, Gsdma3Rim3, Gsdma3I359N, or Gsdma3
M1Btlr (nonsense mutation) expression plasmids together
with increasing amount of C-Gsdma3 expression plas-
mid. We found that the expression levels of the Gsdma3
mutants were generally lower than those of wild-type
Gsdma3 and that increasing C-Gsdma3 expression en-
hanced the protein levels of all Gsdma3 mutants tested,
possibly by alleviating the toxicity of the mutant proteins
(Fig. 5a). Notably, quantitative results showed that a
greater amount of the C-Gsdma3 plasmid was needed to
restore the maximum protein expression of Gsdma3Rim3
and Gsdma3M1Btlr mutants (Fig. 5b). We further exam-
ined the effect of C-Gsdma3 expression on the cytotox-
icity induced by N-Gsdma3 and Gsdma3Rim3 through
flow cytometry analysis (Fig 5c, d). We found that ex-
pressing C-Gsdma3 alleviated cell death (7AAD+) and
△ΨM depolarization (low DiIC1[5]) induced by N-
Gsdma3 and Gsdma3Rim3 plus Gsdma3wt. Also, a greater
amount of the C-Gsdma3 plasmid was needed to block the
cytotoxicity of Gsdma3Rim3 plus Gsdma3wt. Together our
results indicated that expressing C-Gsdma3 masks the
cytotoxicity exerted by N-Gsdma3 or Gsdma3 mutants.
N-Gsdma3 associates with Hsp90 and is delivered to
mitochondria
To investigate how N-Gsdma3 is targeted to mitochon-
dria and induces mitochondrial ROS production, we
used immunoprecipitation and LC-mass spectrometry
analysis to identify its interacting proteins (Fig. 6a,Additional file 3: Figure S3, Additional file 4: Table S1).
We identified Hsp90β, Hsp90α, and Trap1 (Gel1, ap-
proximately 100 kDa) as well as Hsp70 1A, Hsp70 1B,
Stip1/Hop, and Grp75 (Gel2, approximately 70 kDa) as
potential N-Gsdma3-interacting proteins. By coimmuno-
precipitation experiments, we demonstrated that N-
Gsdma3 associated with endogenous Hsp90/Hsp70/Hop
complex, while the co-expressing C-Gsdma3 disrupted
the association between the Hsp90 complex and N-
Gsdma3 (Fig. 6b). Reciprocal co-immunoprecipitation fur-
ther confirmed the association of Hsp90 with N-Gsdma3
(Fig. 6b). In addition, the co-immunoprecipitation experi-
ments confirmed the association between N-Gsdma3 and
the mitochondrial chaperone Trap1/mtHsp75 (Fig. 6d).
Next, we used the Hsp90 inhibitor radicicol to address
the role of Hsp90 association with N-Gsdma3. We found
that radicicol treatment reduced mitochondrial ROS
production, cell death, and △ΨM dissipation induced by
N-Gsdma3 and Gsdma3Rim3 plus Gsdma3wt (Fig 6e-h).
Radicicol treatment did not decrease protein levels of N-
Gsdma3 and Gsdma3Rim3 in transfected HEK293T cells
nor affecting the association of Hsp90/Hsp70 with N-
Gsdma3 or Gsdma3Rim3 (Fig. 6i). As a positive control for
Hsp90 inhibition, we found that the protein level of AKT,
a well-known Hsp90 client, was decreased in a radicicol
concentration-dependent manner in HEK293T cells
(Fig. 6j). Hsp90 has been shown to deliver mitochondrial
preproteins to the mitochondria through the interaction
with Tom70 [26]. Indeed, we found that Tom70 was
present in the N-Gsdma3 immunoprecipitation complex
(Fig. 6k). We performed the proteinase K protection assay
in the fractionated mitochondria isolated from N-Gsdma3-
transfected HEK293T cells treated with vehicle or radicicol
(Fig. 6l). Quantitative results revealed that the mitochon-
drial import of N-Gsdma3 was prevented by radicicol
(Fig. 6m). Collectively, our data indicated that N-Gsdma3
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Fig. 5 C-Gsdma3 blocks the cytotoxicity induced by Gsdma3 mutants. (a) Immunoblot analysis of HEK293T cells transfected with the N-Gsdma3/
flag, Rim3/flag, M1Btlr/V5, or Gsdma3-I359N/V5 plasmid together with an increasing amount of the C-Gsdma3/mh plasmid. The anti-Gsdma3
antibody is more sensitive than the anti-myc-tag antibody. β-actin was used as a loading control. The asterisk indicates a non-specific band due
to the long exposure. (b) Quantification of the immunoblots from (a). The bar graph shows the normalized densitometry levels relative to the
sample co-transfected with 2 μg of the C-Gsdma3/mh plasmid. (c, d) Flow cytometry analysis of the 7AAD and DiIC1(5) staining in HEK293T cells
transfected with different combinations of plasmid constructs as indicated. The bar graphs represent fractions of dead (7AAD+) cells and mitochondrial
membrane potential depolarization (DiIC1(5)low) cells (mean + s.d., n = 3 in duplicates) relative to those in N-Gsdma3- or Rim3 + Gsdma3-trasnfected
cells. pIRES vector-transfected cells were used as the staining baseline.. *, P < 0.05; **, P < 0.01; ***, P < 0.001
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permeability transition ameliorates the cell death induced
by Gsdma3 mutants
The association of N-Gsdma3 with Trap1 led us to in-
vestigate the mechanism of cell death induced by
Gsdma3 mutants. Trap1 has been shown to prevent
mitochondrial oxidative stress and modulate themitochondrial permeability transition (MPT) [27, 28].
Therefore, we first examine whether oxidative stress is
involved in cell death induced by Gsdma3 mutants. We
found that treating the N-Gsdma3- and Gsdma3Rim3-ex-
pressing cells with the ROS scavenger NAC significantly
reduced mitochondrial ROS generation (Fig. 7a, b) as
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Fig. 6 (See legend on next page.)
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Fig. 6 N-Gsdma3 associates with Hsp90 and the mitochondrial chaperone Trap1. (a) Proteomics analysis. Anti-flag immunoprecipitation followed
by SDS-PAGE and silver staining of transfected HEK293T cells. Unique gel bands (Gel1 and Gel2) revealed in the N-Gsdma3 immunoprecipitate
were excised out and processed for proteomics analysis. (b, c) Reciprocal co-immunoprecipitation of Hsp90 and N-Gsdma3. (d) Reciprocal
co-immunoprecipitation of N-Gsdma3 and Trap1. (e, f) Quantification results for MitoSox Red staining. The bar graphs depict the mitochondrial
ROS levels (mean + s.d., n = 3 in duplicates) in radicicol (750 nM)-treated transfected cells relative to those in vehicle-treated transfected cells.
(g, h) Quantification results for 7AAD and DiIC1(5) staining. The bar graphs represent fractions of dead (7AAD+) cells and mitochondrial membrane
potential depolarization (DiIC1(5)low) cells (mean + s.d., n = 3 in duplicates) in radicicol (750 nM)-treated transfected cells relative to those in vehicle-
treated transfected cells. pIRES vector-transfected cells were used as the staining baseline. ***, P < 0.001. No apparent cell death was induced by 750
nM radicicol treatment of HEK293T cells for 20 hours. (i) Co-immunoprecipitation of N-Gsdma3 and Gsdma3Rim3 with Hsp90/Hsp70 in transfected
HEK293T cells in the absence or presence of 750 nM radicicol. (j) Immunoblot analysis of AKT protein in HEK293T cells after treatment with radicicol
(250, 750, 1000 nM) for 20 hours. β-actin was used as a loading control. Relative densitometry intensities are indicated above the protein bands. (k)
Reciprocal co-immunoprecipitation of Tom70 and N-Gsdma3 in the absence or presence of 750 nM radicicol (l) Immunoblot analysis of fractionated
mitochondria from transfected HEK293T cells in the absence or presence of 750 nM radicicol either left untreated (-) or treated with 5 μg/ml proteinase
K (+PK). Tom20 was used as an indicator of PK treatment; Cox4 was used as the loading control. (m) Quantification of the PK protection assay. The bar
graph depicts the densitometry levels of N-Gsdma3 in the radicicol-treated preparation relative to the untreated preparation (mean + s.d., n = 3)
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Gsdma3Rim3-expressing cells was not as great as that ob-
served in N-Gsdma3-expressing cells. Our results suggest
that N-Gsdma3 alters the cytoprotective ability of Trap1
against oxidative stress and that ROS generation precedes
△ΨM dissipation.
Excessive mitochondrial oxidative stress has been in-
volved in the cytochrome c release from the mitochon-
dria and MPT pore opening [29, 30]. Indeed, we
observed elevated level of cytochrome c release into the
cytosol in Gsdma3-, N-Gsdma3-, and Rim3-trasnfected
HEK293T cells (Fig. 7e). We therefore investigated
whether caspase-dependent apoptosis or other cell death
mechanism is involved in the cell death induced by
Gsdma3 mutants (Fig. 7f ). Using pharmacological inhibi-
tors for key mediators in apoptosis and necroptosis
pathways [31], we first found that the pan-caspase in-
hibitor z-VAD-fmk did not block the cell death induced
by N-Gsdma3. In addition, we found no evidence of inhi-
biting cell death when treating N-Gsdma3-expressing cells
with inhibitors for RIPK1 (Necrostain-1), necrosis
(Necrox-5), PARP (ABT-888), acid sphingomyelinase
(desipramine), pan-calpain and cathepsins proteases
(E64D), and adenine nucleotide translocase (bongk-
rekic acid) (Fig. 7f ). Interestingly, treating N-Gsdma3-
and Gsdma3Rim3-expressing cells with a cyclophilin D
inhibitor, cyclosporin A (CsA), reduced fractions of cell
death (Fig. 7g). The suppressive effect of CsA on
Gsdma3Rim3-expressing cells was not as great as that
observed in N-Gsdma3-expressing cells, suggesting that
Gsdma3Rim3 may induce unregulated MPT [27, 32]. In
summary, our data indicate that the Gsdma3 mutants can
induce caspase-independent cell death by oxidative stress-
mediated MPT.
Discussion
In this study, we provide evidence that Gsdma3 contains
a functional N-terminal domain (N-Gsdma3) and a
regulatory C-terminal domain (C-Gsdma3). Mutationsin the C-Gsdma3 disrupt the association between its N-
and C-terminal domains. The unmasked N-Gsdma3
associates with Hsp90 and is delivered to mitochondria
via Tom70, where it induces mitochondrial ROS produc-
tion and cell death. Co-expressing C-Gsdma3 with the
Gsdma3 mutants abrogated their cytotoxicity. Further-
more, pharmacological interventions of mitochondrial
translocation, ROS production, and MPT pore opening
alleviate the cell death induced by Gsdma3 mutants.
Our data suggest a novel function of Gsdma3 in modu-
lating mitochondrial oxidative stress, which potentially
involves in cellular differentiation and cell death.
All of the Gsdma3 mutants tested in our study ap-
peared to exhibit a lower expression level than wild-type
Gsdma3, suggesting that the dominant phenotype might
be caused by haploinsufficiency. However, our further
analyses suggest that these dominant mutations are
gain-of-function mutations. The dominant mutations in
Gsdma3 mutants may expose their N-Gsdma3 and then
enhance the exposure of N-Gsdma3 of wild-type
Gsdma3, a dominant-active effect. Importantly, our find-
ings readily explain why the Dfl- and M1Btlr-type muta-
tions of Gsdma3, which generate C-terminal truncation
mutants, induce dominant phenotypes similar to these
missense mutations in animals [9, 18]. Intriguingly, we
noted that different amounts of C-Gsdma3 were
required to alleviate the cytotoxicity of Gsdma3 mutants.
As suggested by Takana et al [15], different locations of
the mutation sites in Gsdma3 may generate differential
impact on the active conformation of Gsdma3, account-
ing for the slightly different onset of phenotypic defect.
To investigate the mode of action of Gsdma3, we
examined the subcellular localization of N-Gsdma3 and
found that N-Gsdma3 exhibited a perinuclear punctate
pattern that partially colocalized with fragmented mito-
chondria. Mitochondrial fission is known to segregate
damaged or dysfunctional mitochondria for degradation
[33], consistent with our finding that N-Gsdma3 induced
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Fig. 7 Inhibition of ROS and the mitochondrial permeability transition alleviates cell death induced by Gsdma3 mutants. (a, b) Quantification
results for MitoSox Red staining. Bar graphs depict the mitochondrial ROS levels (mean + s.d., n = 3 in duplicates) in NAC-treated transfected cells
relative to vehicle-treated transfected cells. (c, d) Quantification results for 7AAD and DiIC1(5) staining. Bar graphs depict the fractions of dead
(7AAD+) cells and mitochondrial membrane potential depolarization (DiIC1(5)low) cells (mean + s.d., n = 3 in duplicates) in NAC-treated transfected
cells relative to vehicle-treated transfected cells. (e) Immunoblot analysis of cytochrome c release in the cytosolic fraction of transfected HEK293T
cells. GAPDH was used as a loading control. Relative densitometry levels normalized to GAPDH expressions are indicated. (f) Quantification of
7-AAD staining in bar graphs representing the fraction of dead (7AAD+) cells (mean + s.d., n = 3) in inhibitor-treated N-Gsdma3 transfected cells
relative to vehicle-treated N-Gsdma3 transfected cells. n.s., not significant, P = 0.29. (g) Quantification results of 7AAD staining. Bar graphs depict
the fraction of dead (7AAD+) cells (mean + s.d., n = 5 in duplicates) in CsA-treated N-Gsdma3 transfected cells relative to vehicle-treated
2N-Gsdma3 transfected cells. pIRES vector-transfected cells were used as the staining baseline. *, P < 0.05; **, P < 0.01; ***, P < 0.001
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N-Gsdma3-expressing cells, the reduced colocalization of
Gsdma3Rim3 mutant protein with mitochondria may be due
to the random distribution of the mutant protein prior to cell
death, a secondary effect resulting from stronger toxicity of
Gsdma3Rim3. We noted that Gsdma3 does not contain an ap-
parent N-terminal mitochondrial targeting sequence that
could be recognized by Tom20 for mitochondrial import. In-
stead, our data suggest that N-Gsdma3 is delivered to the
mitochondria by the Hsp90/Hsp70/Hop complex via the
mitochondrial importer Tom70, which recognizes the in-
ternal targeting sequences for mitochondrial import [34].
Hsp90/Hsp70 has been shown to deliver a subset of mito-
chondrial preproteins to Tom70 [26], and the formation
of preprotein import intermediate after docking with
Tom70 can be prevented by the Hsp90 inhibitor [35],
consistent with the results of our proteinase K protection
assay. Pharmacological intervention of Hsp90 may also
decrease Ripk1 protein level, which accounts for the inhi-
biting effect of radicicol on cell death induced by
Gsdma3 mutants. However, inhibiting Ripk1 directly by
necrostatin-1 did not rescue cell death induced by N-
Gsdma3, indicating that mitochondrial targeting is crucial
for Gsdma3 activation.
Mitochondrial ROS, mainly superoxide anions, are
thought to be produced by electrons leaking from the
mitochondrial respiratory chain. Thus, increased mito-
chondrial ROS production likely reflects impaired oxi-
dative phosphorylation and is accompanied by △ΨM
depolarization [36]. Our finding that N-Gsdma3 associ-
ates with the mitochondrial chaperone Trap1 may ex-
plain the underlying mechanism of mitochondrial
dysfunction caused by Gsdma3 mutants. Trap1 has been
shown to associate with components of the electron
transport chain [37–39] as well as with CypD [40], a
crucial regulator of the MPT. Moreover, silencing
Trap1 with siRNA increases ROS production, while
Trap1 overexpression attenuates cell death induced by oxida-
tive stress [28, 41]. Thus, we hypothesize that N-Gsdma3 al-
ters Trap1 chaperone activity, which causes mitochondrial
oxidative stress, △ΨM dissipation, and MPT pore opening,
ultimately leading to mitochondrial failure and cell death. Inthe extreme situation, obliterating Trap1 activity by
Gsdma3Rim3 might result in the formation of unregulated
MPT pore by aggregated/misfolded proteins [27, 32], which
cannot be reversed completely by the ROS scavenger NAC
or the CypD inhibitor CsA.
Overexpression of GSDMA and Gsdma3 has been
reported to induce caspase activity in gastric cell lines
and to upregulate caspase 3 expression in keratinocyte
cell lines, respectively [6, 16]. Interestingly, our data
indicate that Gsdma3 mutant can also induce caspase-
independent MPT-mediated cell death. Accumulating
evidence has shown that the extent of MPT determines
the fate of the stressed cells [42]. If MPT happens to a
moderate degree, the cell may undergo apoptosis,
whereas if MPT happens to a larger degree, the cell may
undergo necrotic cell death due to bioenergetic crisis. It
is likely that overexpression of Gsdma3 (a regulatable
form) induces transient MPT pore opening, which
causes the cytochrome c release and caspase activation,
whereas overexpression of Gsdma3 mutant (a constitu-
tively activated form) induces sustained MPT opening,
which causes non-selective release of proapoptotic and
pronecrotic factors as well as uncoupling of oxidative
phosphorylation. Because the protein expression level in
the physiological state can only partially be compared
with that in a transient transfection cell culture system,
the enormous cell death observed in vitro is less likely to
occur in cells expressing Gsdma3 or its mutant in vivo.
Previous studies showed that Gsdma3 is expressed in
the differentiating keratinocytes of the epidermis [9, 15].
Basal keratinocytes leave the basement membrane and
start to differentiate, during which they withdraw from
the cell cycle and become dead corneocytes by a special-
ized cell death program referred to as cornification [43].
Mitochondrial ROS has been shown to play a role in
epidermal differentiation [44] and cyctochrome c release
during keratinocyte differentiation was suggested to acti-
vate gene expression [45]. Therefore, imbalance of the
differentiation and cell death processes can compromise
the skin barrier formation and cause skin disease. We
surmise that cancer cells often reside in hypoxia and
inflammatory microenvironment, which causes redox
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alteration of GSDMA3. In contrast, GSDMA3 is kept in
a closed conformation in normal epithelial cells, and it
may sensitize epithelial cells in response to environmen-
tal factors, such as allergens, infectious agents, or phys-
ical stress. It will be interesting in future experiments to
indentify the physiological signals for exposing the N-
terminal domain of Gsdma3.
Conclusions
Our results revealed that Gsdma3 is regulated by intra-
molecular fold-back inhibition. The genetic mutations in
the C-terminal domain of Gsdma3 are gain-of-function
mutations which unmask the N-terminal functional
domain of Gsdma3. Gsdma3 regulates mitochondrial
oxidative stress through mitochondrial targeting.
Additional files
Additional file 1: Figure S1. The association between Gsdma3wt and
Gsdma3Rim3 and the expression of untagged C-Gsdma3 can recue the
expression of N-Gsdma3, related to Fig. 3. (A) Immunoblot analysis of
HEK293T cells transfected with equal amounts of Gsdma3/V5 or Rim3/V5
plasmids. β-actin was used as a loading control. (B, C, D) Co-
immunoprecipitation of Gsdma3wt and Gsdma3Rim3. WCLs from
HEK293T cells transfected with the indicated plasmid constructs
were immunoprecipitated (IP) and immunoblotted (IB) with the
indicated antibodies. The immunoblots were stripped and re-probed to
detect the immunoprecipitated tagged constructs; WCLs (input) were
immunoblotted to detect the expression of the tagged constructs.
(E) The N-Gsdma3 protein level is upregulated by expressing C-Gsdma3
but not C-Rim3. Immunoblot analysis of HEK293T cells transfected with the
indicated plasmid constructs. The molecular weight of the protein standards
in kilodaltons (kDa) is indicated. Non-specific bands corresponding to the
IgG heavy chain (IgGh) are indicated.
Additional file 2: Figure S2. N-Gsdma3 partially colocalizes with
mitochondria in 293 T kideney epithelial cells and A549 lung epithelial cells.
Both 293 T cells (A) and A549 cells (B) were transfected with Gsdma3/V5
and N-Gsdma3/mh plasmids, and double immunostained for the tag and
the mitochondrial marker Tom20. The color coding indicates the secondary
antibody labeling. DAPI counterstains the nuclei in blue. Arrows indicate
partial colocalization; arrowheads point to mitochondria; Scale bar: 20 μM.
Additional file 3: Figure S3. Trap1 fragment identified with Mascot
software, related to Fig. 6.
Additional file 4: Table S1. Identification of proteins from 1D gel
bands through nanoLC-MS/MS analysis.
Abbreviations
Hsp: Heat-shock protein; Tom: Translocase of outer mitochondrial
membrane; GSDMA: GASDERMIN A; Gsdma3: Gasdermin A3; Trap1: TNF
receptor-associated protein 1; Stip1: Stress-induced-phosphoprotein 1;
ROS: Reactive oxygen species; VDAC: Voltage-dependent anion channel;
ANT: Adenine nucleotide translocase; CypD: Cyclophilin D;
MPT: Mitochondrial permeability transition; ENU: N-ethyl-N-nitrosourea;
TUNEL: Terminal dUTP nick end-labeling; IRES: Internal ribosome entry site;
hrGFP: Humanized recombinant GFP.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
L-TY performed the conception and design of experiments, confocal
microscopy, flow cytometry, data analysis, drafting and revising themanuscript. C-CK performed the mass spectrometric analysis. P-HL performed
the plasmid construction, cell transfection, immunoprecipitation, and western
blot. H-YL performed the immunostaining. All authors read and approved
the final manuscript.
Acknowledgments
We thank Drs. Shau-Ku Huang (NHRI, Taiwan), Jan Sap (Paris Diderot University,
France), and Chi-Hon Lee (NIH, USA) for critical suggestions on the manuscript.
We thank Shu-Hui Wu for helping immunostaining and flow cytometry. We also
thank the NHRI core facilities for flow cytometry, confocal microscopy, and
proteomics studies. This study was supported by grants from NHRI
(01A1-CSPP12-014, 02A1-CSPP12-014), NSC (100-2314-B-400-003-MY3),
and MOST (103-2320-B-400-011-MY3).
Received: 6 March 2015 Accepted: 27 May 2015
References
1. Lippens S, Hoste E, Vandenabeele P, Agostinis P, Declercq W. Cell death in
the skin. Apoptosis Int J Programmed Cell Death. 2009;14(4):549–69.
2. Hao K, Bosse Y, Nickle DC, Pare PD, Postma DS, Laviolette M, et al. Lung
eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet.
2012;8(11):e1003029.
3. Saeki N, Usui T, Aoyagi K, Kim DH, Sato M, Mabuchi T, et al. Distinctive
expression and function of four GSDM family genes (GSDMA-D) in normal
and malignant upper gastrointestinal epithelium. Genes Chromosomes
Cancer. 2009;48(3):261–71.
4. Tamura M, Tanaka S, Fujii T, Aoki A, Komiyama H, Ezawa K, et al. Members
of a novel gene family, Gsdm, are expressed exclusively in the epithelium
of the skin and gastrointestinal tract in a highly tissue-specific manner.
Genomics. 2007;89(5):618–29.
5. Saeki N, Kuwahara Y, Sasaki H, Satoh H, Shiroishi T. Gasdermin (Gsdm)
localizing to mouse Chromosome 11 is predominantly expressed in upper
gastrointestinal tract but significantly suppressed in human gastric cancer
cells. Mammalian Genome Off J Int Mammalian Genome Soc.
2000;11(9):718–24.
6. Saeki N, Kim DH, Usui T, Aoyagi K, Tatsuta T, Aoki K, et al. GASDERMIN,
suppressed frequently in gastric cancer, is a target of LMO1 in TGF-
beta-dependent apoptotic signalling. Oncogene. 2007;26(45):6488–98.
7. Lluis A, Schedel M, Liu J, Illi S, Depner M, von Mutius E, et al. Asthma-
associated polymorphisms in 17q21 influence cord blood ORMDL3 and
GSDMA gene expression and IL-17 secretion. J Allergy Clin Immunol.
2011;127(6):1587–94. e1586, 2011.
8. Yu J, Kang MJ, Kim BJ, Kwon JW, Song YH, Choi WA, et al. Polymorphisms
in GSDMA and GSDMB are associated with asthma susceptibility, atopy and
BHR. Pediatr Pulmonol. 2011;46(7):701–8.
9. Lunny DP, Weed E, Nolan PM, Marquardt A, Augustin M, Porter RM.
Mutations in gasdermin 3 cause aberrant differentiation of the hair follicle
and sebaceous gland. J Invest Dermatol. 2005;124(3):615–21.
10. Runkel F, Marquardt A, Stoeger C, Kochmann E, Simon D, Kohnke B, et al.
The dominant alopecia phenotypes Bareskin, Rex-denuded, and Reduced Coat
2 are caused by mutations in gasdermin 3. Genomics. 2004;84(5):824–35.
11. Kumar S, Rathkolb B, Budde BS, Nurnberg P, de Angelis MH, Aigner B, et al.
Gsdma3(I359N) is a novel ENU-induced mutant mouse line for studying the
function of Gasdermin A3 in the hair follicle and epidermis. J Dermatol Sci.
2012;67(3):190–2.
12. Lei M, Yang T, Lai X, Bai X, Qiu W, Lian X, et al. Upregulation of interfollicular
epidermal and hair infundibulum beta-catenin expression in Gsdma3 mutant
mice. Acta Histochem. 2013;115(1):63–9.
13. Lei MX, Gao X, Yang L, Yang T, Lian XH. Gsdma3 gene is needed for the
induction of apoptosis-driven catagen during mouse hair follicle cycle.
Histochem Cell Biol. 2011;136(3):335–43.
14. Li J, Zhou Y, Yang T, Wang N, Lian X, Yang L. Gsdma3 is required for hair
follicle differentiation in mice. Biochem Biophys Res Commun.
2010;403(1):18–23.
15. Tanaka S, Tamura M, Aoki A, Fujii T, Komiyama H, Sagai T, et al. A new
Gsdma3 mutation affecting anagen phase of first hair cycle. Biochem
Biophys Res Commun. 2007;359(4):902–7.
16. Lei M, Bai X, Yang T, Lai X, Qiu W, Yang L, et al. Gsdma3 is a new factor
needed for TNF-alpha-mediated apoptosis signal pathway in mouse skin
keratinocytes. Histochem Cell Biol. 2012;138(3):385–96.
Lin et al. Journal of Biomedical Science  (2015) 22:44 Page 18 of 1817. Porter RM, Jahoda CA, Lunny DP, Henderson G, Ross J, McLean WH, et al.
Defolliculated (dfl): a dominant mouse mutation leading to poor sebaceous
gland differentiation and total elimination of pelage follicles. J Invest
Dermatol. 2002;119(1):32–7.
18. Ruge F, Glavini A, Gallimore AM, Richards HE, Thomas CP, O’Donnell VB,
et al. Delineating immune-mediated mechanisms underlying hair follicle
destruction in the mouse mutant defolliculated. J Invest Dermatol.
2011;131(3):572–9.
19. Zhou Y, Jiang X, Gu P, Chen W, Zeng X, Gao X. Gsdma3 mutation causes
bulge stem cell depletion and alopecia mediated by skin inflammation.
Am J Pathol. 2012;180(2):763–74.
20. Tsujimoto Y, Nakagawa T, Shimizu S. Mitochondrial membrane permeability
transition and cell death. Biochim Biophys Acta. 2006;1757(9-10):1297–300.
21. Green DR, Reed JC. Mitochondria and apoptosis. Science.
1998;281(5381):1309–12.
22. Yang LT, Nichols JT, Yao C, Manilay JO, Robey EA, Weinmaster G. Fringe
glycosyltransferases differentially modulate Notch1 proteolysis induced
by Delta1 and Jagged1. Mol Biol Cell. 2005;16(2):927–42.
23. Shoshan-Barmatz V, Keinan N, Abu-Hamad S, Tyomkin D, Aram L. Apoptosis
is regulated by the VDAC1 N-terminal region and by VDAC oligomerization:
release of cytochrome c. AIF Smac/Diablo Biochimica Biophysica Acta.
2010;1797(6-7):1281–91.
24. Tsoi H, Li L, Chen ZS, Lau KF, Tsui SK, Chan HY. The SARS-coronavirus
membrane protein induces apoptosis via interfering with PDK1-PKB/Akt
signalling. Biochem J. 2014;464(3):439–47.
25. Kuo CC, Kuo CW, Liang CM, Liang SM. A transcriptomic and proteomic
analysis of the effect of CpG-ODN on human THP-1 monocytic leukemia
cells. Proteomics. 2005;5(4):894–906.
26. Young JC, Hoogenraad NJ, Hartl FU. Molecular chaperones Hsp90 and
Hsp70 deliver preproteins to the mitochondrial import receptor Tom70.
Cell. 2003;112(1):41–50.
27. Altieri DC, Stein GS, Lian JB, Languino LR. TRAP-1, the mitochondrial Hsp90.
Biochim Biophys Acta. 2012;1823(3):767–73.
28. Montesano GN, Chirico G, Pirozzi G, Costantino E, Landriscina M, Esposito F.
Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from
oxidative stress and apoptosis. Stress. 2007;10(4):342–50.
29. Loor G, Kondapalli J, Iwase H, Chandel NS, Waypa GB, Guzy RD, et al.
Mitochondrial oxidant stress triggers cell death in simulated ischemia-
reperfusion. Biochim Biophys Acta. 2011;1813(7):1382–94.
30. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress
and cell death. Apoptosis Int J Programmed Cell Death. 2007;12(5):913–22.
31. Galluzzi L, Kroemer G. Necroptosis: a specialized pathway of programmed
necrosis. Cell. 2008;135(7):1161–3.
32. Altieri DC. Hsp90 regulation of mitochondrial protein folding: from
organelle integrity to cellular homeostasis. Cell Mol Life Sci CMLS.
2013;70(14):2463–72.
33. Westermann B. Bioenergetic role of mitochondrial fusion and fission.
Biochim Biophys Acta. 2012;1817(10):1833–8.
34. Brix J, Dietmeier K, Pfanner N. Differential recognition of preproteins by the
purified cytosolic domains of the mitochondrial import receptors Tom20,
Tom22, and Tom70. J Biol Chem. 1997;272(33):20730–5.
35. Fan AC, Bhangoo MK, Young JC. Hsp90 functions in the targeting and outer
membrane translocation steps of Tom70-mediated mitochondrial import.
J Biol Chem. 2006;281(44):33313–24.
36. Le Bras M, Clement MV, Pervaiz S, Brenner C. Reactive oxygen species and
the mitochondrial signaling pathway of cell death. Histol Histopathol.
2005;20(1):205–19.
37. Chae YC, Angelin A, Lisanti S, Kossenkov AV, Speicher KD, Wang H, et al.
Landscape of the mitochondrial Hsp90 metabolome in tumours. Nat
Commun. 2013;4:2139.
38. Sciacovelli M, Guzzo G, Morello V, Frezza C, Zheng L, Nannini N, et al. The
mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting
succinate dehydrogenase. Cell Metab. 2013;17(6):988–99.
39. Yoshida S, Tsutsumi S, Muhlebach G, Sourbier C, Lee MJ, Lee S, et al.
Molecular chaperone TRAP1 regulates a metabolic switch between
mitochondrial respiration and aerobic glycolysis. Proc Natl Acad Sci U S A.
2013;110(17):E1604–12.
40. Kang BH, Plescia J, Dohi T, Rosa J, Doxsey SJ, Altieri DC. Regulation of tumor
cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone
network. Cell. 2007;131(2):257–70.41. Hua G, Zhang Q, Fan Z. Heat shock protein 75 (TRAP1) antagonizes reactive
oxygen species generation and protects cells from granzyme M-mediated
apoptosis. J Biol Chem. 2007;282(28):20553–60.
42. Honda HM, Ping P. Mitochondrial permeability transition in cardiac cell
injury and death. Cardiovascular drugs and therapy / sponsored by the
international society of cardiovascular. Pharmacotherapy. 2006;20(6):425–32.
43. Eckhart L, Lippens S, Tschachler E, Declercq W. Cell death by cornification.
Biochim Biophys Acta. 2013;1833(12):3471–80.
44. Hamanaka RB, Glasauer A, Hoover P, Yang S, Blatt H, Mullen AR, et al.
Mitochondrial reactive oxygen species promote epidermal differentiation
and hair follicle development. Sci Signal. 2013;6(261):ra8.
45. Grether-Beck S, Felsner I, Brenden H, Krutmann J. Mitochondrial cytochrome
c release mediates ceramide-induced activator protein 2 activation and
gene expression in keratinocytes. J Biol Chem. 2003;278(48):47498–507.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
